Renaissance Technologies
AGN

Renaissance Technologies’s Allergan Inc AGN Stock Holding History

Renaissance Technologies’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-297,860
Closed -$63.3M – 3573
2014
Q4 		$63.3M Buy
297,860
+104,265
+54% +$20.7M 0.15% 123
2014
Q3 		$34.5M Sell
193,595
-222,800
-54% -$37M 0.09% 253
2014
Q2 		$70.5M Buy
416,395
+251,939
+153% +$39.2M 0.16% 120
2014
Q1 		$20.4M Buy
+164,456
New +$20M 0.05% 470
2013
Q4 		– Sell
-386,360
Closed -$34.9M – 3272
2013
Q3 		$34.9M Sell
386,360
-614,300
-61% -$55.1M 0.08% 274
2013
Q2 		$84.3M Buy
+1,000,660
New +$104M 0.22% 82

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Renaissance Technologies's AGN Position: Q1 2015 in Review

Renaissance Technologies sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 297,860 shares — an estimated $63.3M sold.

Renaissance Technologies first reported a position in AGN in Q2 2013 and held it in 6 quarters. The position peaked at $84.3M in Q2 2013. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Renaissance Technologies reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Renaissance Technologies sold 297,860 Allergan Inc shares in Q1 2015, an estimated $63.3M.
  • Renaissance Technologies first reported a position in Allergan Inc in Q2 2013 and held it in 6 quarters.
  • Renaissance Technologies's Allergan Inc position peaked at $84.3M in Q2 2013.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Renaissance Technologies's 13F filing for Q1 2015, filed 13 May 2015.